![Another PASI Calculator Mobile Medical App from Janssen: Simple, Sophisticated, But Short of a Full Deck - Pharma Marketing Network Another PASI Calculator Mobile Medical App from Janssen: Simple, Sophisticated, But Short of a Full Deck - Pharma Marketing Network](http://3.bp.blogspot.com/-mJYB19N2F0g/UopwPn5ZF-I/AAAAAAAAGc4/xRJNATI2yW4/s1600/PASI-JanssenKoreaScreen.jpg)
Another PASI Calculator Mobile Medical App from Janssen: Simple, Sophisticated, But Short of a Full Deck - Pharma Marketing Network
![Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b5fe1753c6637c3d8d05d3474c75480496dc8b7/7-Figure1-1.png)
Figure 1 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar
![Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness](https://pub.mdpi-res.com/life/life-12-02050/article_deploy/html/images/life-12-02050-g001.png?1670482868)
Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
![Time to Raise the Bar to Psoriasis Area Severity Index 90 and 100 - JDDonline - Journal of Drugs in Dermatology Time to Raise the Bar to Psoriasis Area Severity Index 90 and 100 - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_2829/table1.png)
Time to Raise the Bar to Psoriasis Area Severity Index 90 and 100 - JDDonline - Journal of Drugs in Dermatology
![Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post-hoc Analysis from a Long-term Clinical Study – JCAD | The Journal of Clinical Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post-hoc Analysis from a Long-term Clinical Study – JCAD | The Journal of Clinical](https://jcadonline.com/wp-content/uploads/September2020BurgeTable1.jpg)
Early Treatment Targets for Predicting Long-term Dermatology Life Quality Index Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post-hoc Analysis from a Long-term Clinical Study – JCAD | The Journal of Clinical
Get Psorted: Understanding Psoriasis - Find the PASI assessment process confusing? Check out this simple explanation about the Psoriasis Area and Severity Index (PASI) and how it works to assess the intensity
![Figure 2: Relationship between Psoriasis Area and Severity Index (PASI) and Simplified PASI (SPASI) scores Figure 2: Relationship between Psoriasis Area and Severity Index (PASI) and Simplified PASI (SPASI) scores](https://escholarship.org/content/qt18w9j736/Figure2_files/image003.png)
Figure 2: Relationship between Psoriasis Area and Severity Index (PASI) and Simplified PASI (SPASI) scores
![Form HLTH5379 Download Fillable PDF or Fill Online Psoriasis Area and Severity Index (Pasi) Worksheet British Columbia Canada | Templateroller Form HLTH5379 Download Fillable PDF or Fill Online Psoriasis Area and Severity Index (Pasi) Worksheet British Columbia Canada | Templateroller](https://data.templateroller.com/pdf_docs_html/2133/21338/2133865/page_1_thumb_950.png)
Form HLTH5379 Download Fillable PDF or Fill Online Psoriasis Area and Severity Index (Pasi) Worksheet British Columbia Canada | Templateroller
![Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study | HTML | Acta Dermato-Venereologica Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/html-editor/table-pdf/big/5597/5597_21214.png)
Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study | HTML | Acta Dermato-Venereologica
![PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5e273e28-94f9-4a61-be41-3d02ba8af628/ajd13738-tbl-0001-m.jpg)
PASI vs PO‐PASI: Patient‐Oriented PASI (PO‐PASI) is comparable to clinician score PASI - Montes de Oca Pedrosa - 2022 - Australasian Journal of Dermatology - Wiley Online Library
![The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis | Semantic Scholar The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/206b3763bd2ce81db7cd8b22499cd629438e6d66/4-Table2-1.png)
The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis | Semantic Scholar
![JCM | Free Full-Text | Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study JCM | Free Full-Text | Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study](https://www.mdpi.com/jcm/jcm-09-02170/article_deploy/html/images/jcm-09-02170-g001.png)
JCM | Free Full-Text | Use of Guselkumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A 1 Year Real-Life Study
![Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5b5fe1753c6637c3d8d05d3474c75480496dc8b7/8-Table3-1.png)
Table 3 from Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. | Semantic Scholar
![Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study - Richard - 2021 - Journal of](https://onlinelibrary.wiley.com/cms/asset/85d48eca-71ce-42ea-9c50-3f367fac9326/jdv16893-fig-0001-m.jpg)